Induction of lung lesions in female rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin

Toxicologic Pathology

Volumn 28, Issue 6, 2000, Pages 761-769

  Tritscher, A M ^a   Mahler, J ^a   Portier, C J ^a   Lucier, G W ^a   Walker, N J ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

CYP1A1; Half life; Hyperplasia; Metaplasia; TCDD; Tissue concentration

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CARCINOGEN; CYTOCHROME P450 1A1; DIETHYLNITROSAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL HYPERPLASIA; CLARA CELL; CONTROLLED STUDY; FEMALE; LUNG ALVEOLUS; LUNG TOXICITY; METAPLASIA; NONHUMAN; POLLUTANT; PRIORITY JOURNAL; RAT;

ANIMALIA; ZEA MAYS;

EID: 0033664584     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262330002800601     Document Type: Article

References (40)

1. Promotion of mouse lung tumors by bioaccumulated polychlorinated aromatic hydrocarbons
2. Promotion of N-nitrosodimethylamine-initiated mouse lung tumors following single or multiple low dose exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin
3. Promotion of N-nitrosodiethylamine-initiated hepatocellular tumors and hepatoblastomas by 2,3,7,8-tetrachlorodibenzo-p-dioxin or Aroclor 1254 in C57BL/6, DBA/2, and B6D2F1 mice
4. Cancer incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin
5. Dioxin exposure and cancer risk: A 15-year mortality study after the 'Seveso accident'
6. Tumor promotion by TCDD in female rats
7. Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures
8. Liver regeneration versus direct hyperplasia
9. Ovarian cancer in rats induced by chronic 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment
10. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin
11. Regulation of gene expression and acceleration of differentiation in human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin
12. Animal models of human response to dioxins
13. Actions of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on human epidermal keratinocytes in culture
14. Interindividual difference in expression of human Ah receptor and related P450 genes
15. Sequential analysis of the pathogenesis of plutonium-induced pulmonary neoplasms in the rat: Morphology, morphometry, and cytokinetics
16. Carcinogenicity of TCDD: Experimental, mechanistic, and epidemiologic evidence
17. Histochemical, light and electron microscopic study of polonium-210 induced peripheral tumors in hamster lungs: Evidence implicating the Clara cell as the cell of origin
18. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats
19. Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins: An expanded and updated international cohort study
20. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic loci in a two-stage model for rat hepatocarcinogenesis
21. Neoplasms and related proliferative lesions in control Sprague-Dawley rats from carcinogenicity studies: Historical data and diagnostic considerations
22. Goblet cell metaplasia in the pulmonary alveolar epithelium in a rat
23. Pulmonary bioavailability and fine particle enrichment of 2,3,7,8-tetrachlorodibenzo-p-dioxin in respirable soil particles
24. Morphogenesis of alveolar bronchiolization
25. Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: Detection by the polymerase chain reaction
26. Correlation between serum and adipose tissue levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin in 50 persons from Missouri
27. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity
28. Histologic characterization of mouse bronchiolar cell hyperplasia, metaplasia, and neoplasia induced intratracheally by 3- methylcholanthrene
29. Ah receptor mediating induction of aryl hydrocarbon hydroxylase: Detection in human lung by binding of 2,3,7,8-[3H]tetrachlorodibenzo-p-dioxin
30. Subcellular localization of TCDD differs between the liver, lungs, and kidneys after acute and subchronic exposure: Species/dose comparisons and possible mechanism
31. A pharmacodynamic analysis of TCDD-induced cytochrome P450 gene expression in multiple tissues: Dose-and time-dependent effects
32. Ah receptor signaling pathways
33. Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin
34. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: Quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver
35. Differences in kinetics of induction and reversibility of TCDD-induced changes in cell proliferation and CYP1A1 expression in female Sprague-Dawley rat liver
36. Hepatocarcinogenesis in female Sprague-Dawley rats following discontinuous treatment with 2,3,7,8 tetrachlorodibenzo-p-dioxin
37. Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action
38. Target organ specificity of cell proliferation induced by various carcinogens